PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Ending Cash Position : $265 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk Ending Cash Position?

PT Kalbe Farma Tbk's Ending Cash Position for the quarter that ended in Mar. 2024 was $265 Mil.

PT Kalbe Farma Tbk's quarterly Ending Cash Position increased from Sep. 2023 ($175 Mil) to Dec. 2023 ($210 Mil) and increased from Dec. 2023 ($210 Mil) to Mar. 2024 ($265 Mil).

PT Kalbe Farma Tbk's annual Ending Cash Position declined from Dec. 2021 ($436 Mil) to Dec. 2022 ($251 Mil) and declined from Dec. 2022 ($251 Mil) to Dec. 2023 ($210 Mil).

PT Kalbe Farma Tbk Ending Cash Position Historical Data

The historical data trend for PT Kalbe Farma Tbk's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Ending Cash Position Chart

PT Kalbe Farma Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

215.30

369.23

435.65

251.08

209.68

PT Kalbe Farma Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															231.11	182.52	174.99	209.68	264.68

PT Kalbe Farma Tbk Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PT Kalbe Farma Tbk's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	256.213	+	-46.533
	=	210

PT Kalbe Farma Tbk's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	209.679	+	54.997
	=	265

PT Kalbe Farma Tbk Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PTKFF:USA KLBF:Indonesia

Address

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510

Website

https://www.kalbe.co.id

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines